Pharvaris (PHVS) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $27.74, -6.41% vs the prior close of $29.64.
- Volume 1.31M shares, 1.5x its 50-day average.
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
PHVS slides 6.4% to $27.74, a 3-month low, 7 down days in a row. Closed at $27.74, -6.41% vs the prior close of $29.64. Day range $27.70–$29.54, opened at $29.50.
PHVS daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 — PHVS slides 6.4% to $27.74, a 3-month low, 7 down days in a row
- Closed at $27.74, -6.41% vs the prior close of $29.64. Day range $27.70–$29.54, opened at $29.50.
- Volume was 1.31M shares, 1.5x its 50-day average of 850.08K.
- Price is -19.4% vs its 50-day average ($34.41) and -9.6% vs its 200-day average ($30.70).
- 52-week range $20.65–$43.25; today's close sits at 31% of that range, 35.9% below the 52-week high.
- That makes 7 straight losses.
Oct 15, 2026 — PHVS dips 1.3% to $29.64, a 3-month low, 6 down days in a row
- Closed at $29.64, -1.27% vs the prior close of $30.02. Day range $29.23–$30.85, opened at $30.20.
- Volume was 820.40K shares, 1.0x its 50-day average of 841.41K.
- Price is -14.2% vs its 50-day average ($34.54) and -3.4% vs its 200-day average ($30.69).
- 52-week range $20.65–$43.25; today's close sits at 40% of that range, 31.5% below the 52-week high.
- That makes 6 straight losses.
Oct 14, 2026 — PHVS ends flat (+0.0%) to $30.02, 5 down days in a row
- Closed at $30.02, +0.00% vs the prior close of $30.02. Day range $29.80–$30.52, opened at $30.00.
- Volume was 400.40K shares, 0.5x its 50-day average of 838.46K — lighter than usual.
- Price is -13.3% vs its 50-day average ($34.62) and -2.1% vs its 200-day average ($30.67).
- 52-week range $20.65–$43.25; today's close sits at 41% of that range, 30.6% below the 52-week high.
- That makes 5 straight losses.
Oct 13, 2026 — PHVS dips 2.8% to $30.02, a 3-month low, 4 down days in a row
- Closed at $30.02, -2.82% vs the prior close of $30.89. Day range $29.99–$31.20, opened at $30.68.
- Volume was 443.90K shares, 0.5x its 50-day average of 834.68K — lighter than usual.
- Price is -13.5% vs its 50-day average ($34.69) and -2.0% vs its 200-day average ($30.65).
- 52-week range $20.65–$43.25; today's close sits at 41% of that range, 30.6% below the 52-week high.
- That makes 4 straight losses.
Oct 12, 2026 — PHVS dips 0.7% to $30.89, 3 down days in a row
- Closed at $30.89, -0.68% vs the prior close of $31.10. Day range $30.64–$31.93, opened at $31.09.
- Volume was 646.00K shares, 0.8x its 50-day average of 831.90K.
- Price is -11.1% vs its 50-day average ($34.74) and +0.9% vs its 200-day average ($30.63).
- 52-week range $20.65–$43.25; today's close sits at 45% of that range, 28.6% below the 52-week high.
- That makes 3 straight losses.
Oct 9, 2026 — PHVS ends flat (-0.1%) to $31.10
- Closed at $31.10, -0.06% vs the prior close of $31.12. Day range $31.09–$31.96, opened at $31.14.
- Volume was 755.00K shares, 0.9x its 50-day average of 827.05K.
- Price is -10.6% vs its 50-day average ($34.77) and +1.6% vs its 200-day average ($30.60).
- 52-week range $20.65–$43.25; today's close sits at 46% of that range, 28.1% below the 52-week high.
Oct 8, 2026 — PHVS dips 1.8% to $31.12
- Closed at $31.12, -1.77% vs the prior close of $31.68. Day range $30.30–$31.57, opened at $31.57.
- Volume was 628.20K shares, 0.8x its 50-day average of 821.93K.
- Price is -10.6% vs its 50-day average ($34.83) and +1.8% vs its 200-day average ($30.58).
- 52-week range $20.65–$43.25; today's close sits at 46% of that range, 28.0% below the 52-week high.
Oct 7, 2026 — PHVS rises 1.8% to $31.68
- Closed at $31.68, +1.80% vs the prior close of $31.12. Day range $30.58–$32.32, opened at $30.97.
- Volume was 341.80K shares, 0.4x its 50-day average of 819.20K — lighter than usual.
- Price is -9.1% vs its 50-day average ($34.86) and +3.7% vs its 200-day average ($30.55).
- 52-week range $20.65–$43.25; today's close sits at 49% of that range, 26.8% below the 52-week high.
Oct 6, 2026 — PHVS rises 2.1% to $31.12
- Closed at $31.12, +2.07% vs the prior close of $30.49. Day range $30.15–$31.27, opened at $30.50.
- Volume was 778.40K shares, 1.0x its 50-day average of 807.90K.
- Price is -10.8% vs its 50-day average ($34.90) and +2.0% vs its 200-day average ($30.52).
- 52-week range $20.65–$43.25; today's close sits at 46% of that range, 28.0% below the 52-week high.
Oct 5, 2026 — PHVS dips 2.2% to $30.49, a 3-month low
- Closed at $30.49, -2.24% vs the prior close of $31.19. Day range $30.15–$31.47, opened at $31.19.
- Volume was 816.20K shares, 1.0x its 50-day average of 796.68K.
- Price is -12.8% vs its 50-day average ($34.95) and +0.0% vs its 200-day average ($30.48).
- 52-week range $20.65–$43.25; today's close sits at 44% of that range, 29.5% below the 52-week high.
Oct 2, 2026 — PHVS rises 0.6% to $31.19
- Closed at $31.19, +0.58% vs the prior close of $31.01. Day range $30.69–$31.55, opened at $31.21.
- Volume was 591.40K shares, 0.7x its 50-day average of 792.18K.
- Price is -11.0% vs its 50-day average ($35.03) and +2.4% vs its 200-day average ($30.45).
- 52-week range $20.65–$43.25; today's close sits at 47% of that range, 27.9% below the 52-week high.
PHVS latest news & SEC filings
Every SEC filing by or about PHVS in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 13, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Lu Peng had withheld for taxes 109 shares at $31.10 (≈$3.39K) on Oct 11, 2026; now holds 110,152
- Lu Peng had withheld for taxes 117 shares at $31.10 (≈$3.64K) on Oct 12, 2026; now holds 110,035
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 25, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Monges Viviane converted options/RSUs into 11,969 shares at $8.05 (≈$96.35K) on Sep 23, 2026; now holds 17,469
- Monges Viviane sold 11,969 shares at $33.05 (≈$395.52K) on Sep 23, 2026; now holds 5,500
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 24, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Lu Peng converted options/RSUs into 45,308 shares at $2.59 (≈$117.35K) on Sep 22, 2026; now holds 110,261
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 24, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Schikan Johannes Gerardus Christiaan Petrus converted options/RSUs into 800 shares at $20.00 (≈$16.00K) on Sep 22, 2026; now holds 115,967
- Schikan Johannes Gerardus Christiaan Petrus sold 800 shares at $36.19 (≈$28.95K) on Sep 22, 2026; now holds 115,167
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 23, 2026 · Form 144 — Planned insider sale
Notice of proposed sale (Form 144) — an insider or affiliate plans to sell restricted or control shares
A notice of intent, not a completed sale. Any actual sale by a director or officer shows up later on Form 4.
Sep 23, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Nassif David W. sold 6,000 shares at $36.47 (≈$218.80K) on Sep 21, 2026; now holds 114,300
- Nassif David W. gifted 500 shares on Sep 21, 2026; now holds 113,800
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 8, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Sep 8, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Aug 14, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 12, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Jul 31, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Jun 26, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Things to know before you trade PHVS
- How much it moves: over the last 20 sessions the average daily move was 1.77% (largest 6.4%).
- Liquidity: about 683.95K shares (≈$18.97M) trade per day on average.
- 52-week position: $27.74 vs a range of $20.65–$43.25 (31% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 25 sales; latest: Viviane Monges sold 11,969 shares on Sep 23, 2026.
- Latest filings: 6-K Sep 8, 2026; 6-K Sep 8, 2026; 6-K Aug 12, 2026.
- Listing: Nasdaq · industry: Pharmaceutical Preparations.
PHVS market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 29.50 | 29.54 | 27.70 | 27.74 | 1.31M |
| Oct 15, 2026 | 30.20 | 30.85 | 29.23 | 29.64 | 820.40K |
| Oct 14, 2026 | 30.00 | 30.52 | 29.80 | 30.02 | 400.40K |
| Oct 13, 2026 | 30.68 | 31.20 | 29.99 | 30.02 | 443.90K |
| Oct 12, 2026 | 31.09 | 31.93 | 30.64 | 30.89 | 646.00K |
| Oct 9, 2026 | 31.14 | 31.96 | 31.09 | 31.10 | 755.00K |
| Oct 8, 2026 | 31.57 | 31.57 | 30.30 | 31.12 | 628.20K |
| Oct 7, 2026 | 30.97 | 32.32 | 30.58 | 31.68 | 341.80K |
| Oct 6, 2026 | 30.50 | 31.27 | 30.15 | 31.12 | 778.40K |
| Oct 5, 2026 | 31.19 | 31.47 | 30.15 | 30.49 | 816.20K |
| Oct 2, 2026 | 31.21 | 31.55 | 30.69 | 31.19 | 591.40K |
| Oct 1, 2026 | 31.74 | 31.98 | 30.90 | 31.01 | 654.30K |
| Sep 30, 2026 | 31.84 | 32.05 | 31.14 | 31.72 | 839.80K |
| Sep 29, 2026 | 31.93 | 32.34 | 31.23 | 31.73 | 459.20K |
| Sep 28, 2026 | 32.00 | 32.46 | 31.39 | 31.91 | 753.30K |
| Sep 25, 2026 | 33.08 | 33.62 | 31.96 | 32.02 | 597.60K |
| Sep 24, 2026 | 32.88 | 33.84 | 31.91 | 32.99 | 949.00K |
| Sep 23, 2026 | 35.19 | 35.31 | 32.87 | 33.07 | 654.20K |
| Sep 22, 2026 | 35.82 | 36.27 | 34.90 | 35.20 | 588.60K |
| Sep 21, 2026 | 36.33 | 36.88 | 35.50 | 36.02 | 653.70K |
About Pharvaris
Pharvaris (PHVS) is listed on the Nasdaq and classified by the SEC under “Pharmaceutical Preparations”. Its business address is in LEIDEN. State of incorporation: Netherlands. Fiscal year ends December 31. SEC CIK 1830487.
PHVS board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Elisabeth Bjork | Director | Sep 21, 2026 |
| Robert Glassman | Director | Sep 21, 2026 |
| David P Meeker | Director | Mar 18, 2026 |
| Berndt Modig | Chief Executive Officer | Sep 21, 2026 |
| Viviane Monges | Director | Sep 25, 2026 |
| Johannes Gerardus Christiaan Petrus Schikan | Director | Sep 24, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Stefan Andreas Abele | Chief Technical Ops Officer | Sep 17, 2026 |
| Annick Deschoolmeester | Chief Human Resources Officer | Mar 18, 2026 |
| Anne Lesage | Chief Early Development | Sep 21, 2026 |
| Peng Lu | President | Sep 24, 2026 |
| Berndt Modig | Chief Executive Officer | Sep 21, 2026 |
| David W. Nassif | CFO / CLO | Sep 23, 2026 |
| Anna Nijdam | Principal Accounting Officer | Jun 8, 2026 |
| Wim Souverijns | Chief Commercial Officer | Sep 16, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Sep 23, 2026 | Viviane Monges | Sale | 11,969 | $33.05 |
| Sep 23, 2026 | Viviane Monges | Sale | 11,969 | $33.05 |
| Sep 23, 2026 | Viviane Monges | Sale | 11,969 | $33.05 |
| Sep 23, 2026 | Viviane Monges | Sale | 11,969 | $33.05 |
| Sep 22, 2026 | Johannes Gerardus Christiaan Petrus Schikan | Sale | 800 | $36.19 |
| Sep 22, 2026 | Johannes Gerardus Christiaan Petrus Schikan | Sale | 800 | $36.19 |
| Sep 22, 2026 | Johannes Gerardus Christiaan Petrus Schikan | Sale | 800 | $36.19 |
| Sep 22, 2026 | Johannes Gerardus Christiaan Petrus Schikan | Sale | 800 | $36.19 |
| Sep 21, 2026 | David W. Nassif | Sale | 6,000 | $36.47 |
| Sep 21, 2026 | David W. Nassif | Sale | 6,000 | $36.47 |
| Sep 21, 2026 | David W. Nassif | Sale | 6,000 | $36.47 |
| Sep 21, 2026 | David W. Nassif | Sale | 6,000 | $36.47 |
| Sep 17, 2026 | Elisabeth Bjork | Sale | 52,500 | $37.89 |
| Sep 17, 2026 | Elisabeth Bjork | Sale | 52,500 | $37.89 |
| Sep 17, 2026 | Elisabeth Bjork | Sale | 52,500 | $37.89 |
PHVS financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| No annual XBRL figures available (foreign filers often report on Form 20-F). | ||||
Latest balance sheet: total assets $—, total liabilities $—, cash $—.
PHVS earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| No 8-K earnings releases in recent filings. | ||
Related stocks · Pharmaceutical Preparations
Eli Lilly (LLY)Johnson & Johnson (JNJ)Merck (MRK)AbbVie (ABBV)Abbott Laboratories (ABT)Pfizer (PFE)Bristol Myers Squibb (BMY)Vertex Pharmaceuticals Inc / Ma (VRTX)Novo Nordisk A S (NVO)Regeneron Pharmaceuticals (REGN)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on PHVS
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.